In 73-week-old spontaneously hypertensive rats, 3 weeks of quinapril treatment significantly reduced mean arterial pressure, urinary protein excretion, and histologic injury scores (P<0.05).
73 week-old normotensive Wistar-Kyoto and spontaneously hypertensive rats evaluated for glomerular dynamics and renal injury.
Quinapril vs Untreated SHR and WKY rats (3 mg/kg/day)
Mean arterial pressure, urinary protein excretion, and histologic injury scores, p=<0.01
p-value: p=<0.01
Abstract Relationships between glomerular dynamics and renal injury, micropuncture and histological studies were assessed in 73 week-old normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats divided into untreated and angiotension-converting enzyme inhibitor–treated (quinapril; 3 mg/kg/day; for 3 weeks) groups. Urinary protein excretion (UPE) and histologic arteriolar (AIS) and glomerular (GIS) injury scores were determined. Mean arterial pressure (MAP) of untreated SHR was increased compared with WKY (200±6 vs 119±4 mm Hg; P 0.01), and filtration fraction (FF) and total renal vascular resistance (RVR) of SHR were increased ( P <0.01). Single-nephron plasma flow (SNPF) of untreated SHR was decreased (174±17 vs 80±9 ml/min; P <0.01), and single-nephron filtration fraction and afferent arteriolar resistance (R A ) were increased (19.4±1.8 vs 30.0±2.5% and 1.90±0.25 vs 9.05±1.35 U, respectively; both P <0.01). Despite reduced SNPF, glomerular capillary pressure (P G ) increased (49.7±0.7 vs 53.8±1.3 mm Hg; P <0.05), the result of efferent arteriolar constriction (1.15±0.18 vs 2.84±0.36 U; P <0.01). Untreated SHR had higher UPE (13.9±1.5 vs 42.8±3.2; mg/100 g per day; P <0.01) and GIS and AIS scores than WKY (4.3±1.1 vs 64.3±8.4 and 16.6±3.1 vs 96.3±14.4; both P <0.01). Quinapril reduced SHR MAP (to 173±7 mm Hg), FF and RVR (all P <0.01) and increased ERPF (to 2.40±0.26 ml/min per g; P <0.05), and P G decreased (to 49.1±1.1 mm Hg; P <0.01); in association with R A and R E (to 5.18±0.8 U; P <0.01 and 1.74±0.31 U; P <0.05). Although quinapril reduced UPE (to 23.6±1.8 mg/100 g per day; P <0.01) with GIS and AIS ( P <0.05) in SHR, these indices remained higher than in WKY. These data demonstrate that SHR naturally develop glomerular hypertension and ischemia with arteriolar constriction and glomerular sclerosis, and that intrarenal hemodynamic, pathologic, and proteinuric changes begin to reverse after 3 weeks of treatment.
Building similarity graph...
Analyzing shared references across papers
Loading...
Kazutoshi Komatsu
Nihon University
Edward D. Fröhlich
General Cardiology
Hidehiko Ono
Dokkyo University
Hypertension
Ochsner Medical Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Komatsu et al. (Wed,) conducted a other in Hypertension. Quinapril vs. Untreated SHR and WKY rats was evaluated on Mean arterial pressure, urinary protein excretion, and histologic injury scores (p=<0.01). In 73-week-old spontaneously hypertensive rats, 3 weeks of quinapril treatment significantly reduced mean arterial pressure, urinary protein excretion, and histologic injury scores (P<0.05).
synapsesocial.com/papers/6a218f7b36bad5b948f1cc30 — DOI: https://doi.org/10.1161/01.hyp.25.2.207